Sanofi offloads 16 consumer health brands to Stada amid CEO Hudson's refocusing effort

Amid a reorganization scheme aimed at slashing costs and prioritizing immunology blockbuster Dupixent, Sanofi is hiving off a clutch of consumer brands sold mainly in Europe.

As part of its quest to streamline consumer healthcare—and eventually spin off the unit as a standalone business—Sanofi will offload 16 consumer health products to Germany’s Stada Arzneimittel, the companies said Monday.